Results 41 to 50 of about 2,935 (197)

Development of the autoinflammatory disease damage index (ADDI) [PDF]

open access: yes, 2016
OBJECTIVES: Autoinflammatory diseases cause systemic inflammation that can result in damage to multiple organs. A validated instrument is essential to quantify damage in individual patients and to compare disease outcomes in clinical studies.
Al-Mayouf, SM   +48 more
core   +6 more sources

Mastocytosis in Children: Literature Review and Own Clinical Observation

open access: yesZdorovʹe Rebenka, 2013
The review of literature presents the data on neoplastic disease — mastocytosis. We provide the modern information of the etiopathogenesis, classification, clinical presentation, methods of diagnosis and treatment in children. We presented own experience
N.V. Nagornaya   +3 more
doaj   +1 more source

Genotypic and phenotypic characteristics of Chinese neonates with cutaneous mastocytosis: a case report and literature review

open access: yesJournal of International Medical Research, 2020
Mastocytosis is an accumulation of clonal mast cells within tissues and it is most commonly caused by an activating mutation in the KIT gene. In this study, we report a neonatal case who presented with diffuse cutaneous mastocytosis (CM) at birth.
Yanfang Li   +4 more
doaj   +1 more source

Delayed Diagnosis of Indolent Systemic Mastocytosis as the Cause of Unexplained Skin Rash: A Case Report

open access: yesCase Reports in Oncology, 2023
Mastocytosis is a heterogeneous group of disorders in which mast cells exhibit clonal proliferation that infiltrates one or more organs. In cutaneous mastocytosis, the mast cells infiltrate the skin only, whereas systemic mastocytosis is diagnosed when ...
Awni Alshurafa   +4 more
doaj   +1 more source

Diagnosis, management and the burden of symptoms of mastocytosis from the physician's perspective: A nationwide study

open access: yesBritish Journal of Haematology, Volume 207, Issue 5, Page 1973-1981, November 2025.
Summary Mastocytosis is categorized into cutaneous mastocytosis (CM), mast cell sarcoma and systemic mastocytosis (SM). Within SM, indolent SM (ISM) is the more frequent subtype. Adult patients with CM but without an extracutaneous biopsy are classified as having mastocytosis in the skin (MIS), a provisional diagnosis.
Julien Rossignol   +15 more
wiley   +1 more source

Mastocitosis cutánea maculopapular infantil: reporte de un caso

open access: yesRevista Médica Clínica Las Condes, 2019
Resumen: Objetivo: Reportar un caso de mastocitosis cutánea maculopapular de inicio en la infancia y realizar una revisión bibliográfica con énfasis en el diagnóstico, estudio, pronóstico y tratamiento.
Renatta de Grazia   +3 more
doaj   +1 more source

Co-Occurrence of neurofibromatosis-1 with urticaria pigmentosa: A Coincidental association?

open access: yesClinical Dermatology Review, 2020
Neurofibromatosis-1 (NF-1) is a neuroectodermal abnormality characterized by multiple neurofibromas, café-au-lait macules, axillary freckling, and Lisch nodules.
Nazneen Zulfikar Arsiwala   +2 more
doaj   +1 more source

Systemic Mastocytosis: Predominantly Involving the Bone, A Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2013
Systemic mastocytosis (SM) is a rare clonal disorder of mast cells that can range from chronic smouldering type to aggressive mast cell leukaemia. It presents with non–specific symptoms like urticaria pigmentosa, unexplained flushing, hypotension and ...
Ketan P Mallya   +4 more
doaj   +1 more source

Mastocitosis cutáneas : a propósito de tres casos de urticaria pigmentosa [PDF]

open access: yes, 2015
Las mastocitosis son un grupo de enfermedades que tienen en común la proliferación y acumulación de mastocitos en la piel y tejidos extracutáneos. El 65% de ellas se inicia en la infancia.
Innocenti, Carolina   +3 more
core  

A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy [PDF]

open access: yes, 2018
Narrowband UVB (NB-UVB) phototherapy and psoralen-UVA (PUVA) photochemotherapy are widely used phototherapeutic modalities for a range of skin diseases.
Ahmad   +119 more
core   +3 more sources

Home - About - Disclaimer - Privacy